Zihan Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zihan Ding has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bo Hei
Department of Neurosurgery, Peking University People’s Hospital, Peking University, Beijing, China
2 shared publications - Wu Zhou
Department of Neurosurgery, the 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
2 shared publications - Yihao Liu
Department of Neurosurgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
2 shared publications Chengcai Li
Department of Neurosurgery, The First Hospital of Hebei Medical University, Shijiazhuang, China; Department of Neurosurgery, Hebei Hospital of Xuanwu Hospital Capital Medical University, Shijiazhuang, China
1 shared publication- Chengyun Wang
Department of Neurosurgery, The Second affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication - Chunliang Wang
Department of Neurosurgery, the 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication
Latest Publications
- 24 April 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11268-11285
Inhibition of FOXD3 O-GlcNAc Modification Ameliorates Spinal Cord Injury by Promoting STUB1-Mediated Ubiquitination Degradation of HMGB1
Spinal cord injury (SCI) is a serious complication of spinal fractures and/or dislocations, characterized by sensory and motor dysfunction in the trunk and limbs. The pathogenesis of SCI is highly complex and remains poorly understood. The role of O-GlcNAc modification and FOXD3 in SCI was studied in this study. The cell and animal models of SCI were established by H2O2 stimulation and heavy object impact method, respectively. HE and Nissl staining were used to analyze pathological changes and neuronal loss in the spinal cord tissues. The motor ability of rats was assessed by BBB score, ladder climbing, and grid climbing tests. Cell viability and apoptosis were assessed by CCK8, flow cytometry, and TUNEL staining, respectively. Co-IP assay detected O-GlcNAc modification level of FOXD3 protein. The interaction between FOXD3 and STUB1 promoter was analyzed by dual luciferase reporter gene and ChIP assays. O-GlcNAc modification level was significantly elevated in the cell and animal models of SCI. O-GlcNAc modification increased both the protein stability and expression of FOXD3. O-GlcNAc modification inhibition or FOXD3 knockdown reduced oxidative stress damage and apoptosis in H2O2-treated PC12 cells. Moreover, FOXD3 mediated transcriptional inhibition of STUB1, and STUB1 induced HMGB1 ubiquitination and degradation in PC12 cells. STUB1 knockdown or HMGB1 overexpression negated the protective effects of FOXD3 knockdown on H2O2-mediated oxidative stress damage and apoptosis in PC12 cells. Inhibiting the O-GlcNAc modification of FOXD3 alleviated oxidative stress damage and apoptosis in nerve cells to mitigate SCI by enhancing STUB1-induced HMGB1 ubiquitination degradation.
- 24 April 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11268-11285
Inhibition of FOXD3 O-GlcNAc Modification Ameliorates Spinal Cord Injury by Promoting STUB1-Mediated Ubiquitination Degradation of HMGB1
Spinal cord injury (SCI) is a serious complication of spinal fractures and/or dislocations, characterized by sensory and motor dysfunction in the trunk and limbs. The pathogenesis of SCI is highly complex and remains poorly understood. The role of O-GlcNAc modification and FOXD3 in SCI was studied in this study. The cell and animal models of SCI were established by H2O2 stimulation and heavy object impact method, respectively. HE and Nissl staining were used to analyze pathological changes and neuronal loss in the spinal cord tissues. The motor ability of rats was assessed by BBB score, ladder climbing, and grid climbing tests. Cell viability and apoptosis were assessed by CCK8, flow cytometry, and TUNEL staining, respectively. Co-IP assay detected O-GlcNAc modification level of FOXD3 protein. The interaction between FOXD3 and STUB1 promoter was analyzed by dual luciferase reporter gene and ChIP assays. O-GlcNAc modification level was significantly elevated in the cell and animal models of SCI. O-GlcNAc modification increased both the protein stability and expression of FOXD3. O-GlcNAc modification inhibition or FOXD3 knockdown reduced oxidative stress damage and apoptosis in H2O2-treated PC12 cells. Moreover, FOXD3 mediated transcriptional inhibition of STUB1, and STUB1 induced HMGB1 ubiquitination and degradation in PC12 cells. STUB1 knockdown or HMGB1 overexpression negated the protective effects of FOXD3 knockdown on H2O2-mediated oxidative stress damage and apoptosis in PC12 cells. Inhibiting the O-GlcNAc modification of FOXD3 alleviated oxidative stress damage and apoptosis in nerve cells to mitigate SCI by enhancing STUB1-induced HMGB1 ubiquitination degradation.
- Open Access
- 8 April 2025
- Published by Elsevier in World Neurosurgery
- Vol. 198, 123963
Midsagittal Tissue Bridges as Predictors of Neurological Recovery in Traumatic Cervical Spinal Cord Injury
- 8 April 2025
- Published by Elsevier in World Neurosurgery
- Vol. 198, 123963
Open AccessMidsagittal Tissue Bridges as Predictors of Neurological Recovery in Traumatic Cervical Spinal Cord Injury
- Open Access
- 20 March 2025
- Published by Elsevier in Social Science & Medicine
- Vol. 372, 118005
Global temporal trends in depression incidence among women of childbearing age: A 30-year analysis and projections to 2030
- 20 March 2025
- Published by Elsevier in Social Science & Medicine
- Vol. 372, 118005
Open AccessGlobal temporal trends in depression incidence among women of childbearing age: A 30-year analysis and projections to 2030